For example, overexpression of SYF2 affects the cell cycle or cell proliferation leading to the occurrence and progress of breast cancer (Shi et al., 2017), non-small cell lung cancer (Liu et al., 2015; Chen et al., 2019), and ovarian cancer (Yan et al., 2015). This evidence concerns the gene SYF2 and non-small cell lung carcinoma.